Back to Agenda
Session 23: Interactions with FDA - Part 2
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Principles for Communicating with FDA
- Meeting Etiquette
- Resolving Issues or Disputes with FDA
- Summary on Interacting with FDA
- Advisory Committee Meetings
- Advisory Committee Meeting Video
Have an account?